Company intelligence / Profile preview
D5Pharma
Toronto, Ontario, Canadad5pharma.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
D5Pharma develops targeted medicines using novel DNA aptamers and cancer vaccines. Their MetVax vaccine candidate targets a specific region of CEA to prevent tumor metastasis. Another lead program uses PEGylated DNA aptamers as immunosuppressants for autoimmune and inflammatory diseases. The company leverages proprietary screening technology to rapidly identify functionally relevant nucleic acid therapeutics. No published clinical trial results are available yet; most programs are in preclinical development.
- Therapeutic areas
- OncologyImmunology
- Modalities
- DNA aptamers (single-stranded nucleic acids)Cancer vaccines
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Licensed certain rights from Sunnybrook Research Institutepreviously associated with the founding team behind Molecular Templates.
Beyond the preview
Go deeper on D5Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on D5Pharma.